Blood transcriptome analysis revealed the crosstalk between severe COVID-19 and systemic lupus erythematosus
- PMID: 36775249
- PMCID: PMC9916182
- DOI: 10.1016/j.jinf.2023.02.011
Blood transcriptome analysis revealed the crosstalk between severe COVID-19 and systemic lupus erythematosus
Conflict of interest statement
Conflict of interest We declared no conflicts of interest or competing interests.
Figures


Comment on
-
The high expression of key components of inflammasome and pyroptosis might lead to severe COVID-19 infection in cancer patients.J Infect. 2022 Apr;84(4):e19-e21. doi: 10.1016/j.jinf.2022.01.043. Epub 2022 Feb 3. J Infect. 2022. PMID: 35123961 Free PMC article. No abstract available.
References
-
- Kong R., Sun L., Li H., Wang D. The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease. Autoimmunity. 2022;55(1):1–7. - PubMed
-
- Shin J.I., Lee K.H., Joo Y.H., Lee J.M., Jeon J., Jung H.J., et al. Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review. J Autoimmun. 2019;103 - PubMed
-
- Ugarte-Gil M.F., Alarcón G.S., Izadi Z., Duarte-García A., Reátegui-Sokolova C., Clarke A.E., et al. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Ann Rheum Dis. 2022;81(7):970–978. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical